I interviewed Dr. Sumanta Pal, co-director of the Kidney Cancer Program, City of Hope, about a study he led on the effects of continuing immunotherapy in metastatic kidney cancer patients after it has stopped working.
Episode Sponsored By
https://www.carta.healthcare/
Episode Resources
Review, Subscribe and Share
If you like what you hear please leave a review by clicking here
Make sure you're subscribed to the podcast so you get the latest episodes.
